LOS ANGELES, CA / ACCESSWIRE / August 7, 2018 / StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with SNNLive spoke with Michael Redman, President and CEO of Oncolix, Inc., (OTCQB: ONCX), a clinical-stage biotechnology company developing Prolanta™ for the treatment of ovarian cancer, according to the company’s website (see here: www.oncolixbio.com). The video interview was recorded on Monday, June 4, 2018 at the LD Micro Invitational 2018 in Bel Air, CA.
Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:
You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE, and STOCKTWITS
Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer.
About Oncolix
Oncolix is a clinical-stage biotechnology company developing Prolanta™ for the treatment of ovarian, uterine, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in its first indication, the treatment of ovarian cancer. Prolanta™ is a prolactin receptor antagonist (or blocker) that has demonstrated efficacy in xenograft models through a unique mechanism of action, autophagy. In the current Phase 1 dose-escalation safety trial for the treatment of ovarian cancer, to date there have been no observed serious adverse events and no dose-limiting toxicities. The FDA has approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer.
For more information about Oncolix, Inc., please visit: www.oncolixbio.com.
About StockNewsNow.com
StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.
Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for - all here on StockNewsNow.com.
SOURCE: StockNewsNow.com
